117 related articles for article (PubMed ID: 35129549)
1. Erratum to MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity.
Zhang H; Wang L; Bai J; Jiao W; Wang M
Transl Cancer Res; 2020 Nov; 9(11):7379-7380. PubMed ID: 35129549
[TBL] [Abstract][Full Text] [Related]
2. MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity.
Zhang H; Wang L; Bai J; Jiao W; Wang M
Transl Cancer Res; 2020 Jan; 9(1):346-357. PubMed ID: 35117188
[TBL] [Abstract][Full Text] [Related]
3. Erratum: EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human bladder cancer: Erratum.
Zhou Q; Chen S; Lu M; Luo Y; Wang G; Xiao Y; Ju L; Wang X
Int J Biol Sci; 2022; 18(9):3798-3799. PubMed ID: 35813466
[TBL] [Abstract][Full Text] [Related]
4. Erratum: Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer.
Ma Y; Zhang P; Zhang Q; Wang X; Miao Q; Lyu X; Cui B; Ma H
Oncol Lett; 2022 Jan; 23(1):34. PubMed ID: 34966450
[TBL] [Abstract][Full Text] [Related]
5. Erratum: MicroRNA-769-3p inhibits tumor progression in glioma by suppressing ZEB2 and inhibiting the Wnt/β-catenin signaling pathway.
Wang K; Yang S; Gao Y; Zhang C; Sui Q
Oncol Lett; 2021 Mar; 21(3):228. PubMed ID: 33613717
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer.
Proto MC; Fiore D; Piscopo C; Franceschelli S; Bizzarro V; Laezza C; Lauro G; Feoli A; Tosco A; Bifulco G; Sbardella G; Bifulco M; Gazzerro P
Sci Rep; 2017 Sep; 7(1):11678. PubMed ID: 28916833
[TBL] [Abstract][Full Text] [Related]
7. AOC4P suppresses viability and invasion and induces apoptosis in NSCLC cells by inhibiting the Wnt/β-catenin pathway.
Li F; Rong T; Cao G; Zhai C; Li Q; Gong R; Li G
Chem Biol Interact; 2020 Jul; 325():109110. PubMed ID: 32325081
[TBL] [Abstract][Full Text] [Related]
8. MIER3 suppresses colorectal cancer progression by down-regulating Sp1, inhibiting epithelial-mesenchymal transition.
Peng M; Hu Y; Song W; Duan S; Xu Q; Ding Y; Geng J; Zhou J
Sci Rep; 2017 Sep; 7(1):11000. PubMed ID: 28887525
[TBL] [Abstract][Full Text] [Related]
9. Erratum: Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum.
Ji P; Zhou Y; Yang Y; Wu J; Zhou H; Quan W; Sun J; Yao Y; Shang A; Gu C; Zeng B; Firrman J; Xiao W; Bals R; Sun Z; Li D
Theranostics; 2023; 13(11):3640. PubMed ID: 37441606
[TBL] [Abstract][Full Text] [Related]
10. lncRNA SNHG11 promotes lung cancer cell proliferation and migration via activation of Wnt/β-catenin signaling pathway.
Liu S; Yang N; Wang L; Wei B; Chen J; Gao Y
J Cell Physiol; 2020 Oct; 235(10):7541-7553. PubMed ID: 32239719
[TBL] [Abstract][Full Text] [Related]
11. Erratum: LHX6 Affects Erlotinib Resistance and Migration of
Onco Targets Ther; 2021; 14():2337. PubMed ID: 33854331
[TBL] [Abstract][Full Text] [Related]
12. Erratum: LHX6 Affects Erlotinib Resistance and Migration of
Onco Targets Ther; 2021; 14():253. PubMed ID: 33469305
[TBL] [Abstract][Full Text] [Related]
13. miR-512-5p suppresses the progression of non-small cell lung cancer by targeting β-catenin.
Wang Z; Zhu X; Zhang T; Yao F
Oncol Lett; 2020 Jan; 19(1):415-423. PubMed ID: 31897154
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-catenin pathway promotes acute lung injury induced by LPS through driving the Th17 response in mice.
Cheng L; Zhao Y; Qi D; Li W; Wang D
Biochem Biophys Res Commun; 2018 Jan; 495(2):1890-1895. PubMed ID: 29246763
[TBL] [Abstract][Full Text] [Related]
15. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.
Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT
J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668
[TBL] [Abstract][Full Text] [Related]
16. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
[TBL] [Abstract][Full Text] [Related]
17. KCTD11 inhibits progression of lung cancer by binding to β-catenin to regulate the activity of the Wnt and Hippo pathways.
Yang M; Han YM; Han Q; Rong XZ; Liu XF; Ln XY
J Cell Mol Med; 2021 Oct; 25(19):9411-9426. PubMed ID: 34453479
[TBL] [Abstract][Full Text] [Related]
18. Frizzled-7-targeting antibody (SHH002-hu1) potently suppresses non-small-cell lung cancer via Wnt/β-catenin signaling.
Li K; Mao S; Li X; Zhao H; Wang J; Wang C; Wu L; Zhang K; Yang H; Jin M; Zhou Z; Wang J; Huang G; Xie W
Cancer Sci; 2023 May; 114(5):2109-2122. PubMed ID: 36625184
[TBL] [Abstract][Full Text] [Related]
19. TC-1 (c8orf4) enhances aggressive biologic behavior in lung cancer through the Wnt/β-catenin pathway.
Su K; Huang L; Li W; Yan X; Li X; Zhang Z; Jin F; Lei J; Ba G; Liu B; Wang X; Wang Y
J Surg Res; 2013 Nov; 185(1):255-63. PubMed ID: 23880650
[TBL] [Abstract][Full Text] [Related]
20. Erratum regarding missing patient consent statement in previously published articles.
Trauma Case Rep; 2023 Jun; 45():100814. PubMed ID: 37234592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
